[1]
M. W. Saif, K. Kaley, T. Rodriguez, and M. C. Garcon, “Gemcitabine as Salvage Treatment in Patients with Poorly Differentiated Pancreatic Neuroendocrine Tumors: A Case Series”, JOP. J Pancreas (Online), vol. 15, no. 1, pp. 38–41, Jan. 2014.